AAPL289.85+0.49 (+0.17%) ▲|ABBV249.67-1.97 (-0.78%) ▼|ABT92.66+1.92 (+2.11%) ▲|ACN126.81+2.37 (+1.90%) ▲|ADBE208.69+3.67 (+1.79%) ▲|AMAT688.39-34.62 (-4.79%) ▼|AMD560.27-20.64 (-3.55%) ▼|AMGN362.83+0.71 (+0.19%) ▲|AMT165.40+1.83 (+1.12%) ▲|AMZN236.24-2.11 (-0.88%) ▼|AVGO370.19-7.56 (-2.00%) ▼|AXP339.32+1.07 (+0.32%) ▲|BA218.29+1.82 (+0.84%) ▲|BAC57.45+0.47 (+0.82%) ▲|BKNG180.02+1.78 (+1.00%) ▲|BLK964.15+2.59 (+0.27%) ▲|BMY57.22-0.40 (-0.69%) ▼|BNY145.09+0.48 (+0.33%) ▲|BRK-B500.49+0.10 (+0.02%) ▲|C139.12-0.84 (-0.60%) ▼|CAT1,038.13-26.77 (-2.51%) ▼|CL91.78+0.10 (+0.11%) ▲|CMCSA24.00-0.56 (-2.26%) ▼|COF202.06+1.44 (+0.72%) ▲|COP104.00+0.04 (+0.04%) ▲|COST925.00-10.47 (-1.12%) ▼|CRM163.56+6.90 (+4.40%) ▲|CSCO116.72-0.74 (-0.63%) ▼|CVS103.58+0.13 (+0.13%) ▲|CVX166.48+0.72 (+0.43%) ▲|DE625.06-9.27 (-1.46%) ▼|DHR191.76+1.28 (+0.67%) ▲|DIS97.00+0.75 (+0.77%) ▲|DUK126.33-0.25 (-0.20%) ▼|EMR141.55-1.61 (-1.12%) ▼|FDX315.28+2.15 (+0.69%) ▲|GD359.74+5.50 (+1.55%) ▲|GE374.75+1.02 (+0.27%) ▲|GEV1,151.69-23.17 (-1.97%) ▼|GILD125.78-0.56 (-0.44%) ▼|GM77.20+0.12 (+0.16%) ▲|GOOG353.82+0.49 (+0.14%) ▲|GOOGL357.16-0.22 (-0.06%) ▼|GS1,016.00+4.63 (+0.46%) ▲|HD354.31+1.63 (+0.46%) ▲|HON224.85+0.95 (+0.42%) ▲|IBM286.68+5.47 (+1.95%) ▲|INTC135.25-4.38 (-3.14%) ▼|INTU270.82+9.82 (+3.76%) ▲|ISRG401.82+4.14 (+1.04%) ▲|JNJ252.95-1.02 (-0.40%) ▼|JPM328.29+0.96 (+0.29%) ▲|KO81.62+0.35 (+0.42%) ▲|LIN519.07+0.13 (+0.02%) ▲|LLY1,195.38-4.05 (-0.34%) ▼|LMT518.83+9.37 (+1.84%) ▲|LOW223.16+2.67 (+1.21%) ▲|LRCX408.21-25.12 (-5.80%) ▼|MA514.50+0.90 (+0.18%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.72+0.88 (+1.52%) ▲|MDT79.54+1.31 (+1.67%) ▲|META604.43+41.14 (+7.30%) ▲|MMM160.68-1.23 (-0.76%) ▼|MO72.15+0.20 (+0.28%) ▲|MRK126.86-1.64 (-1.28%) ▼|MS209.85+0.81 (+0.39%) ▲|MSFT376.53+3.51 (+0.94%) ▲|MU1,089.58-64.71 (-5.61%) ▼|NEE87.36-0.37 (-0.42%) ▼|NFLX72.72+1.32 (+1.85%) ▲|NKE42.12+1.08 (+2.62%) ▲|NOW102.66+3.39 (+3.41%) ▲|NVDA195.25-4.84 (-2.42%) ▼|ORCL145.70-0.96 (-0.65%) ▼|PEP139.18+3.78 (+2.79%) ▲|PFE24.11+0.33 (+1.37%) ▲|PG146.41-0.11 (-0.08%) ▼|PLTR123.25+6.58 (+5.64%) ▲|PM179.11-1.74 (-0.96%) ▼|QCOM184.51-0.29 (-0.15%) ▼|RTX189.98+0.32 (+0.17%) ▲|SBUX102.45+0.26 (+0.25%) ▲|SCHW93.35+1.15 (+1.25%) ▲|SO95.66-0.03 (-0.03%) ▼|SPG221.57-2.15 (-0.96%) ▼|T20.81+0.12 (+0.56%) ▲|TMO505.28+4.37 (+0.87%) ▲|TMUS170.88+3.15 (+1.88%) ▲|TSLA422.87+2.27 (+0.54%) ▲|TXN302.33+4.26 (+1.43%) ▲|UBER72.75+0.64 (+0.89%) ▲|UNH418.13+2.78 (+0.67%) ▲|UNP272.74+0.84 (+0.31%) ▲|UPS108.25+0.85 (+0.79%) ▲|USB60.96+0.55 (+0.90%) ▲|V342.20-0.39 (-0.11%) ▼|VZ42.38+0.07 (+0.17%) ▲|WFC84.21+1.57 (+1.90%) ▲|WMT107.91-5.35 (-4.72%) ▼|XOM137.00+0.52 (+0.38%) ▲|AAPL289.85+0.49 (+0.17%) ▲|ABBV249.67-1.97 (-0.78%) ▼|ABT92.66+1.92 (+2.11%) ▲|ACN126.81+2.37 (+1.90%) ▲|ADBE208.69+3.67 (+1.79%) ▲|AMAT688.39-34.62 (-4.79%) ▼|AMD560.27-20.64 (-3.55%) ▼|AMGN362.83+0.71 (+0.19%) ▲|AMT165.40+1.83 (+1.12%) ▲|AMZN236.24-2.11 (-0.88%) ▼|AVGO370.19-7.56 (-2.00%) ▼|AXP339.32+1.07 (+0.32%) ▲|BA218.29+1.82 (+0.84%) ▲|BAC57.45+0.47 (+0.82%) ▲|BKNG180.02+1.78 (+1.00%) ▲|BLK964.15+2.59 (+0.27%) ▲|BMY57.22-0.40 (-0.69%) ▼|BNY145.09+0.48 (+0.33%) ▲|BRK-B500.49+0.10 (+0.02%) ▲|C139.12-0.84 (-0.60%) ▼|CAT1,038.13-26.77 (-2.51%) ▼|CL91.78+0.10 (+0.11%) ▲|CMCSA24.00-0.56 (-2.26%) ▼|COF202.06+1.44 (+0.72%) ▲|COP104.00+0.04 (+0.04%) ▲|COST925.00-10.47 (-1.12%) ▼|CRM163.56+6.90 (+4.40%) ▲|CSCO116.72-0.74 (-0.63%) ▼|CVS103.58+0.13 (+0.13%) ▲|CVX166.48+0.72 (+0.43%) ▲|DE625.06-9.27 (-1.46%) ▼|DHR191.76+1.28 (+0.67%) ▲|DIS97.00+0.75 (+0.77%) ▲|DUK126.33-0.25 (-0.20%) ▼|EMR141.55-1.61 (-1.12%) ▼|FDX315.28+2.15 (+0.69%) ▲|GD359.74+5.50 (+1.55%) ▲|GE374.75+1.02 (+0.27%) ▲|GEV1,151.69-23.17 (-1.97%) ▼|GILD125.78-0.56 (-0.44%) ▼|GM77.20+0.12 (+0.16%) ▲|GOOG353.82+0.49 (+0.14%) ▲|GOOGL357.16-0.22 (-0.06%) ▼|GS1,016.00+4.63 (+0.46%) ▲|HD354.31+1.63 (+0.46%) ▲|HON224.85+0.95 (+0.42%) ▲|IBM286.68+5.47 (+1.95%) ▲|INTC135.25-4.38 (-3.14%) ▼|INTU270.82+9.82 (+3.76%) ▲|ISRG401.82+4.14 (+1.04%) ▲|JNJ252.95-1.02 (-0.40%) ▼|JPM328.29+0.96 (+0.29%) ▲|KO81.62+0.35 (+0.42%) ▲|LIN519.07+0.13 (+0.02%) ▲|LLY1,195.38-4.05 (-0.34%) ▼|LMT518.83+9.37 (+1.84%) ▲|LOW223.16+2.67 (+1.21%) ▲|LRCX408.21-25.12 (-5.80%) ▼|MA514.50+0.90 (+0.18%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.72+0.88 (+1.52%) ▲|MDT79.54+1.31 (+1.67%) ▲|META604.43+41.14 (+7.30%) ▲|MMM160.68-1.23 (-0.76%) ▼|MO72.15+0.20 (+0.28%) ▲|MRK126.86-1.64 (-1.28%) ▼|MS209.85+0.81 (+0.39%) ▲|MSFT376.53+3.51 (+0.94%) ▲|MU1,089.58-64.71 (-5.61%) ▼|NEE87.36-0.37 (-0.42%) ▼|NFLX72.72+1.32 (+1.85%) ▲|NKE42.12+1.08 (+2.62%) ▲|NOW102.66+3.39 (+3.41%) ▲|NVDA195.25-4.84 (-2.42%) ▼|ORCL145.70-0.96 (-0.65%) ▼|PEP139.18+3.78 (+2.79%) ▲|PFE24.11+0.33 (+1.37%) ▲|PG146.41-0.11 (-0.08%) ▼|PLTR123.25+6.58 (+5.64%) ▲|PM179.11-1.74 (-0.96%) ▼|QCOM184.51-0.29 (-0.15%) ▼|RTX189.98+0.32 (+0.17%) ▲|SBUX102.45+0.26 (+0.25%) ▲|SCHW93.35+1.15 (+1.25%) ▲|SO95.66-0.03 (-0.03%) ▼|SPG221.57-2.15 (-0.96%) ▼|T20.81+0.12 (+0.56%) ▲|TMO505.28+4.37 (+0.87%) ▲|TMUS170.88+3.15 (+1.88%) ▲|TSLA422.87+2.27 (+0.54%) ▲|TXN302.33+4.26 (+1.43%) ▲|UBER72.75+0.64 (+0.89%) ▲|UNH418.13+2.78 (+0.67%) ▲|UNP272.74+0.84 (+0.31%) ▲|UPS108.25+0.85 (+0.79%) ▲|USB60.96+0.55 (+0.90%) ▲|V342.20-0.39 (-0.11%) ▼|VZ42.38+0.07 (+0.17%) ▲|WFC84.21+1.57 (+1.90%) ▲|WMT107.91-5.35 (-4.72%) ▼|XOM137.00+0.52 (+0.38%) ▲|
29 C
New York
Wednesday, July 1, 2026

Tag: patient

newssourceFORcompanyinformationcontent1releasesmarket

Studies show promising results for individuals with type 2 diabetes and young children with type 1 diabetes on MiniMed™ 780G system

Data supports the potential of future indication expansion for the MiniMed™ 780G system. LENNY trial results published in Lancet Diabetes & Endocrinology. GALWAY, Ireland and...

Unlock Your Investment Potential: Why Palantir’s Future is a Golden Opportunity

Hey fabulous finance queens! 🌟 Let's chat about Palantir Technologies, the AI software superstar that's been turning heads and racking up wins in the...

Doctor Discount Network Provides Essential Information for Safe Online Phentermine Purchases Amidst Growing Concerns

ELLENTON, Fla., June 20, 2025 /PRNewswire/ -- The convenience of online pharmacies has made them a popular source for prescription medications, including Phentermine, a...

L.A. Net Joins the Healthy Interactions Primary Care Alliance to Empower Practice Facilitators in Driving Structural and Behavioral Changes in Cardiometabolic Care

JACKSON HOLE, Wyo., June 20, 2025 /PRNewswire/ -- Healthy Interactions LLC, a global leader in experiential education for healthcare professionals and patients, proudly announces...

ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

Virtual webinar on June 23, 2025 at 8:00 am ET 
Virtual webinar on June 23, 2025 at 8:00 am ET

PharmAla Files Preliminary Base Shelf Prospectus

Pharmala files short form prospectus

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it entered into a securities purchase agreement with an accredited investor for aggregate gross proceeds of $4.25 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for potential acquisitions, marketing and other general corporate purposes.

Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Elevance Health, Inc. ("Elevance"...

The American Diabetes Association Demonstrates Its Commitment to Curbing the Obesity Epidemic with Obesity Standards of Care

Symposium previews new content for Standards of Care in Overweight and Obesity, designed to improve patient care and outcomes CHICAGO, June 20, 2025 /PRNewswire/...

OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules

OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules

Dr. Konstantinos Zarkadas Unveils National Scholarship to Cultivate Next-Generation Medical Leaders

Prestigious Award to Empower Aspiring Physicians Across the United States 
Prestigious Award to Empower Aspiring Physicians Across the United States

Halozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

SC injection of VYVGART® is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional SAN DIEGO,...

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline.

Dr. Myung Ju Lee Shared Enhanced Deep-Plane Facelift Technique at ISAPS Olympiad World Congress

JEJU, South Korea, June 20, 2025 (GLOBE NEWSWIRE) -- Dr. Myung Ju Lee, MD, PhD, Chief Surgeon at VIP Plastic Surgery Clinic in Jeju, South Korea, a leading Korean plastic surgery clinic, presented groundbreaking research on facelift innovation at the International Society of Aesthetic Plastic Surgery (ISAPS) Olympiad World Congress, held June 18–21, 2025, at Marina Bay Sands, Singapore.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers